Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 169-180 of 1641 results.
"The purpose of this prospective study is to describe the incidence of CRT and FS in midline catheters in intensive care setting and to investigate the association between these events and the clinical characteristics of patients" Puzio et al (2026).
"Standardized electronic CVAD documentation could enhance surveillance, improve patient safety, and reduce manual data collection efforts" Voigt et al (2026).
"Hemodialysis catheter-related bloodstream infections (CRBSIs), primarily driven by microbial colonization and biofilm formation, represent a major cause of morbidity and mortality in patients with end-stage renal disease" Zhou et al (2026).
"We report a case involving a 59-year-old woman with multiple myeloma who experienced CVC rupture following prolonged infusion of undiluted etoposide (VP‑16)" Lei et al (2026).
"To decrease CLABSI rates at a quaternary care children's hospital, a house-wide CLABSI Nurse Champion role was implemented in January 2023" Slebodnick and Carlin (2026).
"Dispensing practices may vary and include constitution of 2-mg ready-to-use vials by nursing staff or thawing of batched frozen syringes from previously cryopreserved larger alteplase vials, which requires pharmacy involvement" Bergland et al (2026).
"This modified ultrasound-guided venipuncture technique represents a feasible and reproducible procedural refinement for non-tunneled PICC insertion in NORA environments" Cirillo et al (2026).
"Midline catheters demonstrated no significant differences in the thrombotic profile compared to PICCs. Therefore, VTE risk alone should not determine catheter choice. Future prospective studies with standardized definitions and improved reporting are essential to guide optimal vascular access choice" Santagata et al (2026).
"Intravenous fluids and vasoactive medications represent the foundation of hemodynamic resuscitation for septic shock. Based on current evidence, initial fluid resuscitation of roughly 30 mL/kg with balanced crystalloids is reasonable for most patients" Graham et al (2026).
"This is the first report of the use of SASS in HD t-CVC. In our experience, SecurAcath® was safe and effective for stabilization of Tesio t-CVC" Guzzi et al (2026).
"This prospective, single-arm, first-in-human study evaluated the feasibility and safety of the fully subcutaneous IO device over a 7-day implant with daily infusions in patients with challenging venous access or CKD" Ulloa et al (2026).
"Nurses who had received prior training in dialysis vascular access management demonstrated better knowledge" Zhao et al (2026).
